首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1485794

質粒 DNA 製造市場，依等級、依應用、依開發階段、依疾病、依國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Plasmid DNA Manufacturing Market, By Grade, By Application, By Development Phase, By Disease, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年04月13日 | 出版商:

AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

報告要點

2023 年，質粒 DNA 製造市場規模為 17.8898 億美元，2024 年至 2032 年複合年成長率為 21.5%。

質粒DNA製造市場-市場動態

研發活動的增加以及遺傳性疾病和傳染病患者的增加推動了市場需求

推動質粒 DNA 製造市場發展的原因有很多，包括研發力度的增加、生物製藥投資的增加以及遺傳異常和傳染病發生頻率的增加。此外，精準醫學的發展和新免疫療法的開發正在推動對基於質粒 DNA 的藥物的需求。監管進步和核准程序縮短促進了市場擴張，使研究發現更快轉化為臨床應用。

質粒 DNA 製造市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 21.5% 左右的複合年成長率成長

根據牌號區隔，預計研發牌號碼將在 2023 年顯示最大的市場佔有率

從應用區隔來看，DNA疫苗是2023年的主導類型

根據開發階段區隔，臨床前治療是2023年的主導類型

依地區分類，北美是 2023 年的主要收入來源

質粒 DNA 製造市場 - 區隔分析：

全球質粒 DNA 製造市場根據等級、應用、開發階段、疾病和地區進行區隔。

市場依等級分為三類：研發級、GMP級。研發級產業主導市場。研發級質粒 DNA 廣泛用於早期研究和開發，使科學家能夠探索新的治療概念並驗證臨床前療效。

根據應用，市場分為兩類：DNA 疫苗、細胞和基因治療、免疫治療和其他。 DNA 疫苗領域在市場上佔據主導地位，並可能在預測期內保持其主導地位。 DNA 疫苗利用免疫系統識別和對抗病原體的能力，為預防傳染病和應對新出現的健康威脅提供了一種有前途的方法。

質粒 DNA 製造市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。

質粒DNA製造市場-競爭格局：

質粒 DNA 製造市場競爭激烈，知名競爭對手透過新穎的製造程序和可擴展的生產能力爭奪霸主地位。公司利用策略聯盟、收購和研發支出來加強其市場地位並擴大其產品範圍。領先公司優先考慮品質保證、合規性和經濟高效的解決方案，以滿足各種應用（包括基因治療、疫苗研究和生物製藥製造）對質粒 DNA 不斷成長的需求。為了保持競爭優勢，企業必須不斷適應不斷變化的市場趨勢和客戶需求。

市場片段
- 依等級分類的質粒 DNA 製造市場片段
- 依開發階段分類的質粒 DNA 製造市場片段
- 依應用分類的質粒 DNA 製造市場片段
- 依疾病分類的質粒 DNA 製造市場片段
- 依國家/地區分類的質粒 DNA 製造市場片段
- 依地區分類的質粒 DNA 製造市場片段
競爭洞察

第 3 章：質粒 DNA 製造主要市場趨勢

質粒 DNA 製造市場促進因素
- 市場促進因素的影響分析
質粒 DNA 製造市場限制
- 市場限制影響分析
質粒 DNA 製造市場機會
質粒DNA製造市場未來趨勢

第 4 章：質粒 DNA 製造業研究

PEST分析
波特五力分析
成長前景圖
規範架構分析

第 5 章：質粒 DNA 製造市場：COVID-19 影響分析

COVID-19 之前的影響分析
COVID-19 後影響分析
- 表現最佳的市場區隔
- 邊際成長市場區隔
- 最寬鬆的市場區隔
- 邊際損失市場區隔

第 6 章：質粒 DNA 製造市場格局

2023 年質粒 DNA 製造市佔分析
依主要製造商分類的故障數據
- 既有參與者分析
- 新興參與者分析

第 7 章：質粒 DNA 製造市場 - 依等級

概述
- 依等級分類的區隔市場佔有率分析
- 研發級
- GMP級

第 8 章：質粒 DNA 製造市場 - 依開發階段

概述
- 依開發階段分類的區隔市場佔有率分析
- 臨床前治療
- 臨床治療
- 上市治療藥物

第 9 章：質粒 DNA 製造市場 - 依應用

概述
- 依應用分類的區隔市場佔有率分析
- DNA疫苗
- 細胞與基因治療
- 免疫療法
- 其他

第 10 章：質粒 DNA 製造市場 - 依疾病分類

概述
- 依開發階段分類的區隔市場佔有率分析
- 傳染病
- 癌症
- 遺傳性疾病
- 其他

第 11 章：質粒 DNA 製造市場 - 依地理位置

介紹
- 依地理位置分類的區隔市場佔有率分析
北美洲
- 概述
- 北美質粒 DNA 製造主要製造商
- 北美市場規模和預測（依國家）
- 北美市場規模和預測（依等級）
- 北美市場規模和預測（依開發階段）
- 北美市場規模和預測（依應用）
- 北美市場規模與預測（依疾病）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲質粒 DNA 製造主要製造商
- 歐洲市場規模和預測（依國家）
- 歐洲市場規模與預測（依等級）
- 歐洲市場規模和預測（依發展階段）
- 歐洲市場規模和預測（依應用）
- 歐洲市場規模與預測（依疾病）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區質粒 DNA 製造主要製造商
- 亞太地區市場規模與預測（依國家）
- 亞太地區市場規模與預測（依等級）
- 依發展階段分類的亞太市場規模和預測
- 亞太地區市場規模與預測（依應用）
- 亞太地區市場規模與預測（依疾病）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲質粒 DNA 製造主要製造商
- 拉丁美洲市場規模與預測（依國家）
- 拉丁美洲市場規模與預測（依等級）
- 拉丁美洲市場規模與預測（依發展階段）
- 拉丁美洲市場規模與預測（依應用）
- 拉丁美洲市場規模與預測（依疾病）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲質粒 DNA 製造主要製造商
- 中東和非洲市場規模及預測（依國家）
- 中東和非洲市場規模及預測（依等級）
- 中東及非洲市場規模及預測（依發展階段）
- 中東和非洲市場規模及預測（依應用）
- 中東和非洲市場規模及預測（依疾病）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 12 章：主要供應商分析 - 質粒 DNA 製造業

競爭儀表板
公司簡介
- Nature Technology
- Cell and Gene Therapy Catapult
- Danaher (Aldevron)
- Kaneka Corp.
- Eurofins Genomics
- Lonza
- Charles River Laboratories
- VGXI, Inc.
- Luminous BioSciences, LLC
- Akron Biotech
- Others

第 13 章：360 度分析師視角

第 14 章：附錄

研究方法論
參考
縮寫
免責聲明
聯絡我們

簡介目錄圖表

Product Code: ANV2696

REPORT HIGHLIGHT

Plasmid DNA Manufacturing Market size was valued at USD 1,788.98 Million in 2023, expanding at a CAGR of 21.5% from 2024 to 2032.

The Global Plasmid DNA Manufacturing Market is seeing substantial expansion and transition, owing to advances in biopharmaceutical study and development. Plasmid DNA, a flexible molecular tool, serves as the basis for a wide range of therapeutic applications, including DNA vaccinations, cell and gene therapy. As the need for personalised medicine and targeted therapies continues to develop, the market for plasmid DNA synthesis is positioned to significantly expand.

Plasmid DNA Manufacturing Market- Market Dynamics

Increasing research and development activities and the rising prevalence of genetic disorders and infectious diseases propel market demand

A variety of reasons are driving the Plasmid DNA Manufacturing marketplace, including increased R&D efforts, increased biopharmaceutical investments, and the rising frequency of genetic abnormalities and infectious illnesses. Furthermore, the move towards precision medicine and the development of new immunotherapies are driving up demand for plasmid DNA-based medicines. Regulatory advances and shortened approval procedures boost market expansion, allowing speedier translation of research discoveries into clinical applications.

Plasmid DNA Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.5% over the forecast period (2024-2032)

Based on Grade segmentation, R&D Grade was predicted to show maximum market share in the year 2023

Based on application segmentation, DNA Vaccines was the leading type in 2023

Based on Development Phase segmentation, Pre-Clinical Therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Plasmid DNA Manufacturing Market- Segmentation Analysis:

The Global Plasmid DNA Manufacturing Market is segmented based on Grade, Application, Development Phase, Disease, and Region.

The market is divided into three categories based on Grade: R&D Grade, GMP Grade. The R&D Grade sector dominates the market. Widely used in early-stage research and development, R&D Grade plasmid DNA enables scientists to explore novel therapeutic concepts and validate preclinical efficacy.

The market is divided into two categories based on application: DNA Vaccines, Cell & Gene Therapy, Immunotherapy, and Others. The DNA vaccine segment dominates the market and is likely to maintain its dominance during the forecast period. Leveraging the immune system's ability to recognize and combat pathogens, DNA vaccines offer a promising approach to preventing infectious diseases and addressing emerging health threats.

Plasmid DNA Manufacturing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Plasmid DNA Manufacturing Market- Competitive Landscape:

The Plasmid DNA Manufacturing Market is competitive, with prominent competitors vying for supremacy via novel manufacturing processes and scalable production capacity. Companies use strategic alliances, acquisitions, and R&D expenditures to strengthen their market position and broaden their product offerings. Leading companies prioritise quality assurance, regulatory compliance, and cost-effective solutions to fulfil the expanding demand for plasmid DNA in a variety of applications, including gene therapy, vaccine research, and biopharmaceutical manufacturing. To sustain their competitive advantage, businesses must constantly adapt to changing market trends and client demands.

Recent Developments:

In February 2023, PackGene Biotech expanded its services with the opening of an innovative GMP biomanufacturing and processing plant in Houston, Texas. This comprises gene therapy programmes that produce cost-effective, dependable, and scalable AAV products. With this development, the business hopes to become a one-stop solution supplier for gene therapy developers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMID DNA MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Nature Technology

Cell and Gene Therapy Catapult

Danaher (Aldevron)

Kaneka Corp.

Eurofins Genomics

Lonza

Charles River Laboratories

VGXI, Inc.

Luminous BioSciences, LLC

Akron Biotech

Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY GRADE- MARKET ANALYSIS, 2019 - 2032

R&D Grade
GMP Grade

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

DNA Vaccines
Cell & Gene Therapy
Immunotherapy
Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DEVELOPMENT PHASE- MARKET ANALYSIS, 2019 - 2032

Pre-Clinical Therapeutics
Clinical Therapeutics
Marketed Therapeutics

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

Infectious Disease
Cancer
Genetic Disorder
Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Plasmid DNA Manufacturing Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Plasmid DNA Manufacturing Market Snippet by Grade
- 2.1.2.Plasmid DNA Manufacturing Market Snippet by Development Phase
- 2.1.3.Plasmid DNA Manufacturing Market Snippet by Application
- 2.1.4.Plasmid DNA Manufacturing Market Snippet by Disease
- 2.1.5.Plasmid DNA Manufacturing Market Snippet by Country
- 2.1.6.Plasmid DNA Manufacturing Market Snippet by Region
2.2.Competitive Insights

3.Plasmid DNA Manufacturing Key Market Trends

3.1.Plasmid DNA Manufacturing Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Plasmid DNA Manufacturing Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Plasmid DNA Manufacturing Market Opportunities
3.4.Plasmid DNA Manufacturing Market Future Trends

4.Plasmid DNA Manufacturing Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Plasmid DNA Manufacturing Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Plasmid DNA Manufacturing Market Landscape

6.1.Plasmid DNA Manufacturing Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Plasmid DNA Manufacturing Market - By Grade

7.1.Overview
- 7.1.1.Segment Share Analysis, By Grade, 2023 & 2032 (%)
- 7.1.2.R&D Grade
- 7.1.3.GMP Grade

8.Plasmid DNA Manufacturing Market - By Development Phase

8.1.Overview
- 8.1.1.Segment Share Analysis, By Development Phase, 2023 & 2032 (%)
- 8.1.2.Pre-Clinical Therapeutics
- 8.1.3.Clinical Therapeutics
- 8.1.4.Marketed Therapeutics

9.Plasmid DNA Manufacturing Market - By Application

9.1.Overview
- 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2.DNA Vaccines
- 9.1.3.Cell & Gene Therapy
- 9.1.4.Immunotherapy
- 9.1.5.Others

10.Plasmid DNA Manufacturing Market - By Disease

10.1.Overview
- 10.1.1.Segment Share Analysis, By Development Phase, 2023 & 2032 (%)
- 10.1.2.Infectious Disease
- 10.1.3.Cancer
- 10.1.4.Genetic Disorder
- 10.1.5.Others

11.Plasmid DNA Manufacturing Market- By Geography

11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2.North America
- 11.2.1.Overview
- 11.2.2.Plasmid DNA Manufacturing Key Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
  - 11.2.8.1.Overview
  - 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3.U.S. Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.2.8.4.U.S. Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.2.8.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.6.U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
  - 11.2.9.1.Overview
  - 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3.Canada Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.2.9.4.Canada Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.2.9.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.6.Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.3.Europe
- 11.3.1.Overview
- 11.3.2.Plasmid DNA Manufacturing Key Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
  - 11.3.8.1.Overview
  - 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3.Germany Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.8.4.Germany Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.8.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.6.Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
  - 11.3.9.1.Overview
  - 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3.Italy Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.9.4.Italy Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.9.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.6.Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
  - 11.3.10.1.Overview
  - 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3.United Kingdom Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.10.4.United Kingdom Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.10.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.6.United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.11.France
  - 11.3.11.1.Overview
  - 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3.France Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.11.4.France Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.11.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.6.France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
  - 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2.Russia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.12.3.Russia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.12.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.5.Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
  - 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2.Netherlands Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.13.3.Netherlands Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.13.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.5.Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
  - 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2.Sweden Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.14.3.Sweden Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.14.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.5.Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
  - 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2.Poland Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.15.3.Poland Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.15.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.5.Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
  - 11.3.16.1.Overview
  - 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3.Rest of the Europe Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.16.4.Rest of the Europe Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.16.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.6.Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Plasmid DNA Manufacturing Key Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.8.India
  - 11.4.8.1.Overview
  - 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3.India Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.8.4.India Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.8.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.6.India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.9.China
  - 11.4.9.1.Overview
  - 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3.China Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.9.4.China Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.9.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.6.China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
  - 11.4.10.1.Overview
  - 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3.Japan Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.10.4.Japan Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.10.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.6.Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
  - 11.4.11.1.Overview
  - 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3.South Korea Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.11.4.South Korea Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.11.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.6.South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
  - 11.4.12.1.Overview
  - 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3.Australia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.12.4.Australia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.12.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.6.Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
  - 11.4.13.1.Overview
  - 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3.Thailand Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.13.4.Thailand Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.13.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.6.Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
  - 11.4.14.1.Overview
  - 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3.Indonesia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.14.4.Indonesia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.14.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.6.Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
  - 11.4.15.1.Overview
  - 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3.Philippines Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.15.4.Philippines Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.15.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.6.Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
  - 11.4.16.1.Overview
  - 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3.Rest of APAC Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.16.4.Rest of APAC Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.16.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.6.Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Plasmid DNA Manufacturing Key Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
  - 11.5.8.1.Overview
  - 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3.Brazil Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.8.4.Brazil Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.8.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.6.Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
  - 11.5.9.1.Overview
  - 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3.Mexico Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.9.4.Mexico Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.9.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.6.Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
  - 11.5.10.1.Overview
  - 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3.Argentina Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.10.4.Argentina Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.10.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.6.Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
  - 11.5.11.1.Overview
  - 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3.Colombia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.11.4.Colombia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.11.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.6.Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
  - 11.5.12.1.Overview
  - 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3.Rest of LATAM Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.12.4.Rest of LATAM Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.12.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.6.Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Plasmid DNA Manufacturing Key Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
  - 11.6.8.1.Overview
  - 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3.Saudi Arabia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.8.4.Saudi Arabia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.8.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.6.Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
  - 11.6.9.1.Overview
  - 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3.United Arab Emirates Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.9.4.United Arab Emirates Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.9.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.6.United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
  - 11.6.10.1.Overview
  - 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3.Israel Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.10.4.Israel Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.10.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.6.Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
  - 11.6.11.1.Overview
  - 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3.Turkey Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.11.4.Turkey Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.11.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.6.Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
  - 11.6.12.1.Overview
  - 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3.Algeria Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.12.4.Algeria Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.12.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.6.Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
  - 11.6.13.1.Overview
  - 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3.Egypt Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.13.4.Egypt Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.13.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.6.Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
  - 11.6.14.1.Overview
  - 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3.Rest of MEA Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.14.4.Rest of MEA Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.14.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.6.Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Plasmid DNA Manufacturing Industry

12.1.Competitive Dashboard
12.2.Company Profiles
- 12.2.1.Nature Technology
- 12.2.2.Cell and Gene Therapy Catapult
- 12.2.3.Danaher (Aldevron)
- 12.2.4.Kaneka Corp.
- 12.2.5.Eurofins Genomics
- 12.2.6.Lonza
- 12.2.7.Charles River Laboratories
- 12.2.8.VGXI, Inc.
- 12.2.9.Luminous BioSciences, LLC
- 12.2.10.Akron Biotech
- 12.2.11.Others

13.360 Degree Analyst View

14.Appendix

14.1.Research Methodology
14.2.References
14.3.Abbreviations
14.4.Disclaimer
14.5.Contact Us

簡介目錄圖表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Plasmid DNA Manufacturing Market: Grade Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Grade
TABLE Global Plasmid DNA Manufacturing Market, by Grade 2019-2032 (USD Million)
TABLE Plasmid DNA Manufacturing Market: Development Phase Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Development Phase
TABLE Global Plasmid DNA Manufacturing Market, by Development Phase 2019-2032 (USD Million)
TABLE Plasmid DNA Manufacturing Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Plasmid DNA Manufacturing Market, by Application 2019-2032 (USD Million)
TABLE Plasmid DNA Manufacturing Market: Disease Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Disease
TABLE Global Plasmid DNA Manufacturing Market, by Disease 2019-2032 (USD Million)
TABLE Plasmid DNA Manufacturing Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Plasmid DNA Manufacturing Market, by Region 2019-2032 (USD Million)
TABLE North America Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
TABLE North America Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
TABLE North America Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
TABLE North America Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
TABLE North America Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
TABLE Europe Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
TABLE Europe Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
TABLE Europe Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
TABLE Europe Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
TABLE Europe Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
TABLE Latin America Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
TABLE Latin America Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
TABLE Latin America Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)